iCAN Signs MoU With Yom Chai for Crohn’s Disease and Autism
- Tuesday, August 21, 2018, 1:43
- Environment
- Add a comment
LONDON, August 21, 2018 /PRNewswire/ — The Directors of Ananda Developments Plc are pleased to announce that investee company iCAN has signed an MoU with a new Israeli Medical Cannabis company Yom Chai to develop and clinically validate cannabis based treatments for Crohn’s Disease,…
Source: https://www.prnewswire.com:443/news-releases/ican-signs-mou-with-yom-chai-for-crohn-s-disease-and-autism-826897662.html
About the Author
adminasapcorp has written 41528 stories on this site.